Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

SILO

Silo Pharma (SILO)

Silo Pharma Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:SILO
DateTimeSourceHeadlineSymbolCompany
23/01/202500:29GlobeNewswire Inc.Silo Pharma Advances Intellectual Property Portfolio with Provisional Patent Filing for PTSD TreatmentNASDAQ:SILOSilo Pharma Inc
09/01/202500:29GlobeNewswire Inc.Silo Pharma Awarded US Patent for Groundbreaking PTSD Treatment and Prepares for SPC-15 Clinical TrialNASDAQ:SILOSilo Pharma Inc
03/01/202503:11Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SILOSilo Pharma Inc
03/01/202500:45GlobeNewswire Inc.Silo Pharma Issues Letter to Shareholders Detailing Development Progress and Potential for Lead Assets Targeting PTSD and Chronic PainNASDAQ:SILOSilo Pharma Inc
21/12/202409:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SILOSilo Pharma Inc
18/12/202423:35GlobeNewswire Inc.Silo Pharma Initiates Pharmacokinetic and Tolerability Study for SP-26 Targeting Chronic Pain and FibromyalgiaNASDAQ:SILOSilo Pharma Inc
17/12/202409:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SILOSilo Pharma Inc
30/11/202400:05GlobeNewswire Inc.Silo Pharma Enters Joint Development Agreement for SP-26 Ketamine Implant Device Targeting Pain ManagementNASDAQ:SILOSilo Pharma Inc
23/11/202408:16Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SILOSilo Pharma Inc
19/11/202400:40GlobeNewswire Inc.Silo Pharma Announces Positive Results for Novel SPC-15 Treatment Targeting Stress-Related DisordersNASDAQ:SILOSilo Pharma Inc
16/11/202409:21Edgar (US Regulatory)Form DEFR14A - Revised definitive proxy soliciting materialsNASDAQ:SILOSilo Pharma Inc
13/11/202408:42Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SILOSilo Pharma Inc
09/11/202408:04Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:SILOSilo Pharma Inc
09/11/202408:03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SILOSilo Pharma Inc
31/10/202423:35GlobeNewswire Inc.Silo Pharma Reports Positive Results in Sterilization and Dissolution Testing of SP-26 Ketamine ImplantNASDAQ:SILOSilo Pharma Inc
19/09/202406:19Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:SILOSilo Pharma Inc
19/09/202406:17Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:SILOSilo Pharma Inc
19/09/202406:15Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:SILOSilo Pharma Inc
10/09/202420:46Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SILOSilo Pharma Inc
10/09/202420:35GlobeNewswire Inc.Silo Pharma Announces Completion of FDA Pre-IND Meeting to Advance Development of SPC-15 for Treatment of PTSDNASDAQ:SILOSilo Pharma Inc
04/09/202414:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:SILOSilo Pharma Inc
22/08/202407:20Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:SILOSilo Pharma Inc
15/08/202404:30GlobeNewswire Inc.Silo Pharma Expands Development Agreement with Sever Pharma for Novel Ketamine Implant TherapeuticNASDAQ:SILOSilo Pharma Inc
14/08/202406:30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SILOSilo Pharma Inc
07/08/202422:13GlobeNewswire Inc.Silo Pharma Announces Partnership with Global CRO for Central Nervous System Homing PeptideNASDAQ:SILOSilo Pharma Inc
03/08/202403:16Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:SILOSilo Pharma Inc
31/07/202414:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:SILOSilo Pharma Inc
27/07/202406:17Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:SILOSilo Pharma Inc
26/07/202422:20GlobeNewswire Inc.Silo Pharma to Present at H.C. Wainwright Annual Global Investment ConferenceNASDAQ:SILOSilo Pharma Inc
26/07/202406:30Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:SILOSilo Pharma Inc
 Showing the most relevant articles for your search:NASDAQ:SILO